胺碘酮治疗急性心肌梗死后室性心律失常的临床分析

Clinical analysis of amiodarone in the treatment of ventricular arrhythmias after acute myocardial infarction

目的分析在急性心肌梗死后室性心律失常患者的临床治疗中胺碘酮的临床应用效果。方法选取2015年1月至2016年1月本院收治的60例急性心肌梗死后室性心律失常患者为研究对象，将所选患者随机均分为对照组和实验组，对照组患者接受利多卡因常规治疗，实验组患者接受胺碘酮治疗。对比两组患者的临床治疗效果及不良反应情况。结果实验组患者的临床治疗效果明显好于对照组，且不良反应例数少于对照组，两组患者的数据经对比存在统计学差异（P〈0．05）。结论在急性心肌梗死后室性心律失常患者的治疗中，胺碘酮的临床疗效较好，值得推广。

Objective To analyze the clinical application value of amiodarone in the treatment of ventricular arrhythmias after acute myocardial infarction. Methods 60 cases of ventricular arrhythmias after acute myocardial infarction treated in our hospital from January 2015 to January 2016 were selected as the research object, and randomly divided into control group and experimental group. Control group received routine lidocaine treatment, while experimental group received amiodarone treatment. Clinical efficacy and adverse reactions of two groups were compared. Results The clinical curative effect of experimental group was significantly better than that of control group, and adverse reactions were less than those of control group, with statistically significant differences between two groups （P〈0.05）. Conclusion In the treatment of patients with ventricular arrhythmias after acute myocardial infarction, amiodarone has better clinical effect, worthy of promotion.